Abbott announced it has received CE Mark in Europe for the AVEIR™ dual chamber (DR) leadless pacemaker system, the world’s first dual chamber leadless pacemaker that trea...
Basel- April 2024- Roche announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumour resection f...
April, 2024- GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of Br...
Dublin- April 2024- Medtronic announced the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software...
Florida, USA- Siemens Healthineers has launched an app designed for Apple Vision Pro that enables users such as surgeons, medical students, or patients to view immersive,...
March 2024- New study released by the Lancet shows that, in 2022, more than 1 billion people in the world are now living with obesity. Worldwide, obesity among adults has...
ABBOTT PARK, Ill., March, 2024 /PRNewswire/ — Abbott (NYSE: ABT) today announced new data from two real-world studies1, 2 showing people with Type 2 diabetes using GLP-1...
February 2024- GSK today announced that it has completed the acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company focused on addressing the unme...
Dubai, UAE –February 2024: The second edition of the Dubai Stem Cell Congress (DSCC) kicked off at Palazzo Versace in Dubai. Its current edition brings together more than...
A virtual marketplace leading your business into the future
